The results indicated that higher ARIH2 expression level was significantly associated with poorer OS (p = 0.015), DSS (p = 0.021), and PFS (p < 0.001) in HCC (Figures 5C-E). Here, ARIH2 is linked to hepatocellular carcinoma.